| BDSCX | FSSNX | BDSCX / FSSNX | |
| Total Expense Ratio | 1.50 | 0.03 | 6,000% |
| Annual Report Gross Expense Ratio | 1.66 | 0.03 | 6,640% |
| Fund Existence | 13 years | 14 years | - |
| Gain YTD | 10.538 | 14.668 | 72% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.4B | 29.3B | 15% |
| Annual Yield % from dividends | 0.02 | 0.80 | 2% |
| Returns for 1 year | 8.27 | 13.24 | 62% |
| Returns for 3 years | 42.15 | 50.13 | 84% |
| Returns for 5 years | 10.08 | 31.66 | 32% |
| Returns for 10 years | 88.98 | 120.25 | 74% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NBRRX | 26.61 | 0.04 | +0.15% |
| Neuberger M/C Intrinsic Val R3 | |||
| PEQKX | 24.87 | 0.02 | +0.08% |
| Victory Pioneer Equity Income R6 | |||
| SINAX | 39.29 | N/A | N/A |
| ClearBridge Large Cap Value A | |||
| IASSX | 10.92 | N/A | N/A |
| VY® American Century Sm-Mid Cp Val S | |||
| JDESX | 48.58 | -0.01 | -0.02% |
| JPMorgan US Research Enhanced Equity I | |||